Milana Bergamino Sirvén

6PUBLICATIONS
54CO-AUTHORS
Molecular targetsEnvironmental epidemiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 01, 2025
Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial.

Mafalda Oliveira, Eva Ciruelos, Guillermo Villacampa

|Jan 17, 2025
Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial.

Maria Vidal, Claudette Falato, Tomás Pascual

|Nov 27, 2024
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Iris Teruel, Eva Castellà, Sabela Recalde

|Feb 02, 2022
Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegans.

Carmen Martínez-Fernández, Milana Bergamino, Alfonso Schiavi

|Dec 30, 2021
Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast Cancers.

Milana A Bergamino, Gabriele Morani, Joel Parker

|Feb 12, 2021
Lights and Shadows in Immuno-Oncology Drug Development.

Milana Bergamino Sirvén, Sonia Pernas, Maggie C U Cheang

Pageof 1

Frequent Collaborators

2 joint publications

Maggie C U Cheang

2 joint publications

Tomás Pascual

2 joint publications

Fernando Salvador

2 joint publications

Juan M Ferrero-Cafiero